July 11, 2026 07:26 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Highway blocked, stones pelted, cops injured': BJP faces open revolt in Madhya Pradesh over Narottam Mishra ticket snub | Two Kolkata Police DCPs suspended over alleged remarks against Bengal CM Suvendu Adhikari | Bail to Bloodbath: Telangana man allegedly kills wife, kids and teen who accused him of sexual harassment | Prakash Raj gets bail in multiple voter registration case linked to 2019 polls | ED raids Shekhar Suman associate's premises in FEMA case; phone allegedly thrown from 13th floor | 'Candidate fled': Prashant Kishor jibes BJP over Bankipur nominee change | BJP replaces candidate days before high-stakes Bankipur bypoll | Foreign franchise league enters India! BBL opener to be played in Chennai, announce Modi-Albanese | 'They could have stopped me': Vijay blames police, former DMK government over Karur stampede | 'People will correct their 2025 mistake': Electoral debutant Prashant Kishor predicts BJP defeat in Bankipur
Covid Vaccine
Image Credit: Pixabay

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

| @indiablooms | Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

Pfizer Inc and BioNTech stated that they have made a request to the US Food and Drug Administration for the expansion of use of their vaccine which proved to be 90 per cent effective against the novel coronavirus in clinical trials.

In March, the drugmakers said that their vaccine has shown positive results and proven safe among the age group 12 to 15 in a clinical trial.

This could be a big development as drugmakers across the world are still facing the question if the vaccine works and is safe for use in children.

Inoculating children is a major step toward achieving "herd immunity" and controlling the pandemic, according to experts, the report said.

The companies plan to approach other regulatory authorities across the globe for similar permissions.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.